We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ranolazine is a piperazine derivative belonging to the anti-anginal class of drugs. It is mainly used for the management of stable angina pectoris. Chronic angina leads to ongoing chest pain or pressure, which is felt when the heart does not receive enoug
Glenmark Pharmaceuticals has been granted final approval by the United States Food and Drug Administration (US FDA) for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg ...